Shoulder Innovations hikes FY26 revenue guidance 48% after Q3 beat

Shoulder Innovations reported a 38% increase in Q3 revenue to $16.2 million and raised full-year guidance to $68-70 million. The commercial-stage company launched the N-22 humeral head to treat metal hypersensitivity, marking a significant step in market share expansion.